Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Sandoz Confirms European Commission Approval of Pyzchiva® (Ustekinumab), Further Strengthening Immunology Offering
Monday, April 22, 2024Sandoz the global leader in generic and biosimilar medicines today announces that the European Commission has granted marketing authorization for Pyzchiva
Aurigene Pharmaceutical Services Ltd., and Vipergen Announce a Strategic Partnership for Offering Dna Encoded Library (DEL) Screening and Integrated Drug Discovery Services.
Saturday, April 20, 2024Aurigene Pharmaceutical Services Ltd a global contract research development
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
Friday, April 19, 2024Evotec SE and Variant Bio Inc today announced a collaboration agreement to identify a bestinclass treatment for diseases caused by fibrosis Fibrosis is characterized by marked and pathogenic buildup
EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research
Friday, April 19, 2024EditCo Bio Inc a pioneer at the forefront of genome engineering innovation today announced the launch of its Knockout CD Tcell Pools This latest addition to EditCo Bios product lineup marks a significant leap forward in CRISPRmediated
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
Friday, April 19, 2024BioPath Holdings Inc a biotechnology company leveraging its proprietary DNAbilize antisense RNAi nanoparticle technology to develop a portfolio
European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)
Friday, April 19, 2024Moleculin Biotech Inc a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hardtotreat tumors and viruses today
IGM Biosciences Announces Refocusing of Sanofi Collaboration
Thursday, April 18, 2024IGM Biosciences Inc a clinicalstage biotechnology company creating and developing engineered IgM antibodies today announced that the Companys exclusive worldwide collaboration agreement
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
Thursday, April 18, 2024Sage Therapeutics Inc announced today topline results from PRECEDENT a doubleblind placebocontrolled
Ose Immunotherapeutics Announces the Entry Into Force of the Global License to Develop an Innovative Monoclonal Antibody in the Treatment of Chronic Inflammation
Wednesday, April 17, 2024OSE Immunotherapeutics SA a clinicalstage immunotherapies company announces the end of the waiting period provided for by the HartScott law Rodino
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
Wednesday, April 17, 2024Cullinan Therapeutics Inc formerly Cullinan Oncology Inc a biopharmaceutical company focused on developing modalityagnostic targeted therapies today announced important updates
